- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06397729
Evaluation of a Novel Technology to Support Tailored Health Behavior Counseling in Rural Primary Care Clinics (Rural PREVENT)
June 10, 2025 updated by: Maura Mohler Kepper, Washington University School of Medicine
This project will conduct a pilot hybrid study that examines the implementation (Aims 1 & 2) and preliminary effectiveness (Aim 3) of PREVENT, a digital health intervention, among patients with overweight/obesity (N=100) using a clinic-randomized design.
The central hypothesis of the study is that PREVENT will be feasible and show improvements in health behavior counseling and the patient experience that will improve patients' motivation to change, and their CVH health behaviors and outcomes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Cardiovascular disease (CVD) prevalence is 40% higher among rural than urban residents in the United States.
Maintaining healthy weight, physical activity, and food intake behaviors promotes cardiovascular health (CVH) and prevents CVD.
The Health Resources and Services Administration requires health behavior counseling and follow-up care for patients with elevated body mass index.
Counseling is most effective when developed with and tailored to the patient and offered with resources that support healthy food intake and physical activity.
Healthcare teams are challenged by the lack of accessible evidence-based, tailored recommendations and limited awareness of patient health behaviors and community resources, all of which are compounded by lack of time within the clinical workflow.
Yet, digital health tools that can facilitate quality counseling and follow-up are not readily available for primary care teams - particularly those in low-resourced rural settings.
The investigators will leverage our existing digital health tool (PREVENT) for healthcare teams, including Community Health Workers (CHWs), to use at the point-of-care with rural low-income patients who are overweight or obese and often have more severe social needs.
PREVENT visually displays patient-reported and electronic health record data to facilitate counseling and deliver tailored physical activity and healthy food intake goals and resources.
The investigators have been working with the Missouri Highlands Health Care, a federally-qualified health center with 10 clinics across 7 rural counties that has an existing CHW network, to adapt our tool to meet the needs of their health care teams and patients.
This project will examine the implementation (Aims 1 & 2) and preliminary effectiveness (Aim 3) of PREVENT among patients with overweight/obesity (N=100) using a clinic-randomized design in four clinics.
The investigators believe that PREVENT will be feasible and show improvements in health behavior counseling and the patient experience that will improve patients' motivation to change, CVH health behaviors, and outcomes.
The investigators will seek to understand factors impacting implementation and sustainment of this approach to streamline the translation of this tool into routine care.
Our ultimate goal is to improve CVH with enhanced health behavior counseling and follow-up using a multi-level approach that targets health behaviors and unmet social needs to give everyone an equal opportunity for health.
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maura Kepper, PhD
- Phone Number: 314-935-0142
- Email: kepperm@wustl.edu
Study Locations
-
-
Missouri
-
St. Louis, Missouri, United States, 63130
- Recruiting
- Washington University in St. Louis
-
Contact:
- Maura Kepper
- Phone Number: 314-935-0142
- Email: kepperm@wustl.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Patient Inclusion Criteria:
- Aged 18-64 years at baseline
- Low income (household income <200% FPL)
- At risk for poor CVH (body mass index greater than or equal to 30)
- Receiving care from the Missouri Highlands Healthcare
- Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable)
Provider Inclusion Criteria:
• All providers and clinic staff (physicians, nurses, community health workers, clinic staff, clinic research associates) in the Missouri Highlands Healthcare Clinics are eligible to participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Patients - Wait-List Control
|
Will receive routine clinical care.
After completion of follow-up measures, control participants will receive a behavior change prescription via the PREVENT tool
|
|
Experimental: Patients- PREVENT Tool
|
PREVENT is a novel Health Information Technology tool designed to promote physical activity and healthy food intake among overweight/obese patients at the point of care.
PREVENT automates the delivery of personalized, evidence-based behavior change recommendations and provides an interactive map of community resources to help the care team link patients to resources in their community.
PREVENT follows up with patients electronically and communicates progress on behavior change to the care team.
|
|
No Intervention: Providers
All eligible providers will be sent questionnaires electronically to their email at baseline, following provider training and follow-up.
Providers will be invited to attend a training session to educate them on the PREVENT tool at baseline.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Healthcare team member confidence
Time Frame: baseline, at study completion (3 years)
|
A survey (4-questions) will assess provider's confidence in delivering health behavior counseling and discussing cardiovascular health with patients.
Questions are asked on a 5-point Likert scale (range: 4-20) with a higher score indicating greater satisfaction.
Change in confidence from baseline to post-study will be compared in intervention clinics versus control clinics.
|
baseline, at study completion (3 years)
|
|
Quality counseling
Time Frame: Within 48 hours of clinic visit
|
A 12 question survey will ask patients 1) if they have been counseled on 10 topics Life's Essential 8 (obesity, blood pressure, physical activity, food intake, smoking, sleep, cholesterol, and diabetes), and two distractor topics (flu vaccination and seat belt use); 2) if they received goals for healthy eating and/or physical activity; and 3) if they received resources to support their health.
Discussion of physical activity and/or food intake will satisfy that health behavior counseling was delivered.
Yes' to physical activity or food intake counseling and 'yes' to receipt of tailored goals and/or resources will satisfy the 'quality behavioral counseling' outcome.
|
Within 48 hours of clinic visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Provider satisfaction
Time Frame: at study completion (3 years)
|
A survey (33-questions) will assess provider's acceptability and satisfaction with five aspects of health information technology (content, accuracy, format, ease of use and timeliness) and PREVENT's fit with their clinic workflow.
Questions are asked on a 5-point Likert scale (range: 33-165) with a higher score indicating greater satisfaction.
|
at study completion (3 years)
|
|
Shared Decision Making
Time Frame: 3 months into study
|
Direct observation of intervention visits will be conducted using the Observing Patient Involvement in Decision Making instrument62 to understand the extent to which the PREVENT tool facilitates shared decision making.
|
3 months into study
|
|
Resource Offering
Time Frame: 6-months
|
The number and type of resources offered will be tracked by PREVENT for each patient
|
6-months
|
|
Patient satisfaction
Time Frame: Within 48 hours of clinic visit
|
A survey (6-questions) will assess patient's satisfaction with the PREVENT tool.
Questions are asked on a 5-point Likert scale (range: 6-30) with a higher score indicating greater satisfaction.
|
Within 48 hours of clinic visit
|
|
Patient motivation to change
Time Frame: at baseline, and 6-months
|
A survey (11-question) administered to patients will assess motivation and self-efficacy for behavior change.
Questions are asked using a 5-point Likert scale (range: 11-55) with a higher score indicating greater motivation.
|
at baseline, and 6-months
|
|
Change in patients knowledge of CVH
Time Frame: at baseline, and 6-months
|
A survey (4-question) administered to patients to assess their knowledge of CVH risk (perceived value/importance of healthy behaviors) and awareness of resources.
Questions are asked using a 5-point Likert scale (range: 4-20) with a higher score indicating greater knowledge.
|
at baseline, and 6-months
|
|
Change in food intake behaviors
Time Frame: at baseline, and 6-months
|
Patients report servings per week or per day for fruit intake, vegetable intake, whole grains, sugar-sweetened beverages, fast food consumption, and snacking behaviors.
|
at baseline, and 6-months
|
|
Change in physical activity behaviors
Time Frame: at baseline, and 6-months
|
Patient-reported physical activity (minutes of moderate and vigorous activity per week) are collected using a survey (4-questions).
Patients report the average number of minutes of moderate and vigorous activity they do per week.
|
at baseline, and 6-months
|
|
Change in body mass index (BMI) index z-score
Time Frame: At baseline, and 6-months
|
Collected from patient's medical record.
|
At baseline, and 6-months
|
|
Change on patient's average systolic and diastolic blood pressure
Time Frame: At baseline, and 6-months
|
Collected from patient's medical record
|
At baseline, and 6-months
|
|
Change in patient's cholesterol at baseline and at study completion
Time Frame: At baseline, and 6-months
|
Collected from patient's medical record
|
At baseline, and 6-months
|
|
Change in patient's blood glucose at baseline and at study completion
Time Frame: At baseline, and 6-months
|
Collected from patient's medical record
|
At baseline, and 6-months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Maura Kepper, PhD, Washington University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2024
Primary Completion (Estimated)
April 30, 2026
Study Completion (Estimated)
July 30, 2026
Study Registration Dates
First Submitted
January 23, 2024
First Submitted That Met QC Criteria
April 30, 2024
First Posted (Actual)
May 3, 2024
Study Record Updates
Last Update Posted (Actual)
June 13, 2025
Last Update Submitted That Met QC Criteria
June 10, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202309157
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Wait-List Control
-
New York State Psychiatric InstituteCompletedCognitive Deterioration | Disorder of AgingUnited States
-
University of OsloNorwegian Institute of Public Health; Norwegian Council for Mental Health; The...CompletedQuality of Life | Wellbeing | Health AttitudeNorway
-
New York State Psychiatric InstituteFeinstein Institute for Medical ResearchCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed
-
Kaohsiung Medical University Chung-Ho Memorial...Kaohsiung Medical UniversityUnknownHead and Neck CancerTaiwan
-
Macmillan Research Group UKNMP Medical Research Institute; Warwick Research ServicesUnknownRheumatic ArthritisIndia
-
Washington University School of MedicineRecruitingCardiovascular Diseases | ObesityUnited States
-
VA Office of Research and DevelopmentCompletedSuicide | Mental HealthUnited States
-
Seattle Children's HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Gynecologic Cancer | Peripheral NeuropathyUnited States